Logo image of 2NN.DE

NN GROUP NV (2NN.DE) Stock Fundamental Analysis

FRA:2NN - Deutsche Boerse Ag - NL0010773842 - Common Stock - Currency: EUR

57.3  +0.48 (+0.84%)

Fundamental Rating

4

2NN gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 38 industry peers in the Insurance industry. The financial health of 2NN is average, but there are quite some concerns on its profitability. 2NN has a decent growth rate and is not valued too expensively. Finally 2NN also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

2NN had positive earnings in the past year.
In the past year 2NN has reported a negative cash flow from operations.
In the past 5 years 2NN has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: 2NN reported negative operating cash flow in multiple years.
2NN.DE Yearly Net Income VS EBIT VS OCF VS FCF2NN.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B

1.2 Ratios

Looking at the Return On Assets, with a value of 0.72%, 2NN is doing worse than 60.53% of the companies in the same industry.
With a Return On Equity value of 7.03%, 2NN is not doing good in the industry: 78.95% of the companies in the same industry are doing better.
2NN has a worse Return On Invested Capital (0.49%) than 71.05% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for 2NN is in line with the industry average of 2.06%.
The 3 year average ROIC (0.31%) for 2NN is below the current ROIC(0.49%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.72%
ROE 7.03%
ROIC 0.49%
ROA(3y)0.67%
ROA(5y)0.8%
ROE(3y)6.62%
ROE(5y)6.79%
ROIC(3y)0.31%
ROIC(5y)0.56%
2NN.DE Yearly ROA, ROE, ROIC2NN.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8

1.3 Margins

Looking at the Profit Margin, with a value of 12.26%, 2NN is in the better half of the industry, outperforming 68.42% of the companies in the same industry.
In the last couple of years the Profit Margin of 2NN has grown nicely.
The Operating Margin of 2NN (10.19%) is worse than 60.53% of its industry peers.
In the last couple of years the Operating Margin of 2NN has remained more or less at the same level.
Industry RankSector Rank
OM 10.19%
PM (TTM) 12.26%
GM N/A
OM growth 3Y-1.79%
OM growth 5Y0.69%
PM growth 3Y-3.58%
PM growth 5Y9.26%
GM growth 3YN/A
GM growth 5YN/A
2NN.DE Yearly Profit, Operating, Gross Margins2NN.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

5

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), 2NN is destroying value.
The number of shares outstanding for 2NN has been reduced compared to 1 year ago.
The number of shares outstanding for 2NN has been reduced compared to 5 years ago.
Compared to 1 year ago, 2NN has an improved debt to assets ratio.
2NN.DE Yearly Shares Outstanding2NN.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
2NN.DE Yearly Total Debt VS Total Assets2NN.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B 200B 250B

2.2 Solvency

2NN has an Altman-Z score of 0.12. This is a bad value and indicates that 2NN is not financially healthy and even has some risk of bankruptcy.
2NN has a better Altman-Z score (0.12) than 78.95% of its industry peers.
2NN has a Debt/Equity ratio of 0.55. This is a neutral value indicating 2NN is somewhat dependend on debt financing.
2NN's Debt to Equity ratio of 0.55 is in line compared to the rest of the industry. 2NN outperforms 55.26% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Altman-Z 0.12
ROIC/WACC0.06
WACC8.26%
2NN.DE Yearly LT Debt VS Equity VS FCF2NN.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B 20B 30B

2.3 Liquidity

A Current Ratio of 1.05 indicates that 2NN should not have too much problems paying its short term obligations.
2NN has a better Current ratio (1.05) than 92.11% of its industry peers.
2NN has a Quick Ratio of 1.05. This is a normal value and indicates that 2NN is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of 2NN (1.05) is better than 92.11% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 1.05
2NN.DE Yearly Current Assets VS Current Liabilites2NN.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B 8B 10B

4

3. Growth

3.1 Past

2NN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 38.30%, which is quite impressive.
2NN shows a decrease in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -0.60% yearly.
2NN shows a small growth in Revenue. In the last year, the Revenue has grown by 0.12%.
2NN shows a very negative growth in Revenue. Measured over the last years, the Revenue has been decreasing by -12.53% yearly.
EPS 1Y (TTM)38.3%
EPS 3Y-18.75%
EPS 5Y-0.6%
EPS Q2Q%66.24%
Revenue 1Y (TTM)0.12%
Revenue growth 3Y-19.29%
Revenue growth 5Y-12.53%
Sales Q2Q%-3.11%

3.2 Future

2NN is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.92% yearly.
Based on estimates for the next years, 2NN will show a small growth in Revenue. The Revenue will grow by 1.63% on average per year.
EPS Next Y9.69%
EPS Next 2Y7.51%
EPS Next 3Y7.54%
EPS Next 5Y7.92%
Revenue Next Year2.55%
Revenue Next 2Y2.89%
Revenue Next 3Y-13.13%
Revenue Next 5Y1.63%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
2NN.DE Yearly Revenue VS Estimates2NN.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 5B 10B 15B 20B
2NN.DE Yearly EPS VS Estimates2NN.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2 4 6 8

5

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 10.25 indicates a reasonable valuation of 2NN.
Based on the Price/Earnings ratio, 2NN is valued a bit cheaper than the industry average as 78.95% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 27.30, 2NN is valued rather cheaply.
A Price/Forward Earnings ratio of 8.11 indicates a reasonable valuation of 2NN.
84.21% of the companies in the same industry are more expensive than 2NN, based on the Price/Forward Earnings ratio.
The average S&P500 Price/Forward Earnings ratio is at 21.76. 2NN is valued rather cheaply when compared to this.
Industry RankSector Rank
PE 10.25
Fwd PE 8.11
2NN.DE Price Earnings VS Forward Price Earnings2NN.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

2NN's Enterprise Value to EBITDA is on the same level as the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 14.18
2NN.DE Per share data2NN.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.06
PEG (5Y)N/A
EPS Next 2Y7.51%
EPS Next 3Y7.54%

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.11%, 2NN is a good candidate for dividend investing.
2NN's Dividend Yield is rather good when compared to the industry average which is at 4.58. 2NN pays more dividend than 86.84% of the companies in the same industry.
2NN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.37.
Industry RankSector Rank
Dividend Yield 6.11%

5.2 History

The dividend of 2NN is nicely growing with an annual growth rate of 15.91%!
Dividend Growth(5Y)15.91%
Div Incr Years2
Div Non Decr Years2
2NN.DE Yearly Dividends per share2NN.DE Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 1 2 3

5.3 Sustainability

45.68% of the earnings are spent on dividend by 2NN. This is a bit on the high side, but may be sustainable.
2NN's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP45.68%
EPS Next 2Y7.51%
EPS Next 3Y7.54%
2NN.DE Yearly Income VS Free CF VS Dividend2NN.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B
2NN.DE Dividend Payout.2NN.DE Dividend Payout, showing the Payout Ratio.2NN.DE Dividend Payout.PayoutRetained Earnings

NN GROUP NV

FRA:2NN (7/11/2025, 7:00:00 PM)

57.3

+0.48 (+0.84%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)02-20 2025-02-20/amc
Earnings (Next)08-08 2025-08-08
Inst Owners52.27%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap15.41B
Analysts73.33
Price Target57.39 (0.16%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 6.11%
Yearly Dividend2.56
Dividend Growth(5Y)15.91%
DP45.68%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)8.51%
PT rev (3m)10.28%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0.79%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.91%
Valuation
Industry RankSector Rank
PE 10.25
Fwd PE 8.11
P/S 1.25
P/FCF N/A
P/OCF N/A
P/B 0.71
P/tB 0.76
EV/EBITDA 14.18
EPS(TTM)5.59
EY9.76%
EPS(NY)7.07
Fwd EY12.34%
FCF(TTM)-1.77
FCFYN/A
OCF(TTM)-1.49
OCFYN/A
SpS45.99
BVpS80.17
TBVpS75.61
PEG (NY)1.06
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.72%
ROE 7.03%
ROCE 0.61%
ROIC 0.49%
ROICexc 0.5%
ROICexgc 0.67%
OM 10.19%
PM (TTM) 12.26%
GM N/A
FCFM N/A
ROA(3y)0.67%
ROA(5y)0.8%
ROE(3y)6.62%
ROE(5y)6.79%
ROIC(3y)0.31%
ROIC(5y)0.56%
ROICexc(3y)0.32%
ROICexc(5y)0.58%
ROICexgc(3y)0.42%
ROICexgc(5y)0.75%
ROCE(3y)0.39%
ROCE(5y)0.7%
ROICexcg growth 3Y-14.7%
ROICexcg growth 5Y-8.18%
ROICexc growth 3Y-16.09%
ROICexc growth 5Y-9.11%
OM growth 3Y-1.79%
OM growth 5Y0.69%
PM growth 3Y-3.58%
PM growth 5Y9.26%
GM growth 3YN/A
GM growth 5YN/A
F-Score5
Asset Turnover0.06
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF N/A
Debt/EBITDA 8.29
Cap/Depr 47.13%
Cap/Sales 0.6%
Interest Coverage 0.93
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.05
Quick Ratio 1.05
Altman-Z 0.12
F-Score5
WACC8.26%
ROIC/WACC0.06
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)38.3%
EPS 3Y-18.75%
EPS 5Y-0.6%
EPS Q2Q%66.24%
EPS Next Y9.69%
EPS Next 2Y7.51%
EPS Next 3Y7.54%
EPS Next 5Y7.92%
Revenue 1Y (TTM)0.12%
Revenue growth 3Y-19.29%
Revenue growth 5Y-12.53%
Sales Q2Q%-3.11%
Revenue Next Year2.55%
Revenue Next 2Y2.89%
Revenue Next 3Y-13.13%
Revenue Next 5Y1.63%
EBIT growth 1Y32.04%
EBIT growth 3Y-20.73%
EBIT growth 5Y-11.93%
EBIT Next Year9.08%
EBIT Next 3Y4.46%
EBIT Next 5YN/A
FCF growth 1Y-866.13%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-746.77%
OCF growth 3YN/A
OCF growth 5YN/A